Nanoparticle Characterization for Cancer Nanotechnology and Other Biological Applications
Nanotechnology is actively being used to develop promising diagnostics and therapeutics tools for the treatment of cancer and many other diseases. The unique properties of nanomaterials offer an exciting frontier of possibilities for biomedical researchers and scientists. Because existing knowledge of macroscopic materials does not always allow for adequate prediction of the characteristics and behaviors of nanoscale materials in controlled environments, much less in biological systems, careful nanoparticle characterization should accompany biomedical applications of these materials. Informed correlations between adequately characterized nanomaterial properties and reliable biological endpoints are essential for guiding present and future researchers toward clinical nanotechnology-based solutions for cancer. Biological environments are notoriously dynamic; hence, nanoparticulate interactions within these environments will likely be comparatively diverse. For this reason, we recommend that an interactive and systematic approach to material characterization be taken when attempting to elucidate or measure biological interactions with nanoscale materials. We intend for this chapter to be a practical guide that could be used by researchers to identify key nanomaterial characteristics that require measurement for their systems and the appropriate techniques to perform those measurements. Each section includes a basic overview of each measurement and notes on how to address some of the common difficulties associated with nanomaterial characterization.
- In Vitro Micronucleus Technique to Predict Chemosensitivity
- Humanization of Monoclonal Antibodies by CDR Grafting
- Energy Balance, Physical Activity, and Cancer Risk
- Classification of AML by DNA-Oligonucleotide Microarrays
- Apoptosis Assessment by the DNA Diffusion Assay
- Analysis of the Mouse Placenta as a Hematopoietic Stem Cell Niche
- 17 Direct Sequencing for Peutz-Jeghers Gene LKB1 (STK11) Mutations
- Quantitative Real-Time PCR Expression Analysis of Peripheral Blood Mononuclear Cells in Pancreatic Cancer Patients
- 干细胞和衰老的终结(第一部分)
- Purification of Growth Factor mRNA in Renal Tissues:bFGF-2, FGF-2, TGFα, and EGFR